PRECLINICAL MDL FOR LABELING, TRANSPLANT, & IMAGING OF DIFFERENTIAL HES CELLS

用于标记、移植、

• 批准号: 7715659
• 负责人: Alice F Tarantal
• 金额: $ 8.13万
• 依托单位: UNIVERSITY OF CALIFORNIA AT DAVIS
• 依托单位国家: 美国
• 财政年份: 2008
• 资助国家: 美国
• 起止时间: 2008-05-01 至 2009-04-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7715659
• 关键词: Cells; Computer Retrieval of Information on Scientific Projects Database; Development; Disease; Funding; Grant; Image; Institution; Kidney; Label; Research; Research Personnel; Resources; Source; Techniques; Transplantation; United States National Institutes of Health; human embryonic stem cell; pre-clinical; repaired

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Objective: Cellular therapy is a potential technique under study for repair of kidneys damaged by disease. In order to effectively develop such approaches, an understanding of the development of the metanephric kidney is essential, particularly for directing human embryonic stem (hES) cells towards renal precursors.

这个子项目是许多研究子项目中的一个 由NIH/NCRR资助的中心赠款提供的资源。子项目和 研究者（PI）可能从另一个NIH来源获得了主要资金， 因此可以在其他CRISP条目中表示。所列机构为 研究中心，而研究中心不一定是研究者所在的机构。 目的：细胞治疗是一种正在研究中的修复肾脏疾病损伤的潜在技术。 为了有效地开发这样的方法，理解后肾的发育是必不可少的，特别是对于将人胚胎干细胞（hES）导向肾前体细胞。